As an initial model system, they used mouse embryonic stem cells (mESCs) that were modified to resemble the genetics of SMA patients (Smn1−/− and carrying human SMN2+/+ and SMNΔ7). Here, SMN2 is linked to proximal spinal muscular atrophy.